Literature DB >> 9464268

Activin A: a commitment factor in erythroid differentiation.

M Shiozaki1, M Kosaka, Y Eto.   

Abstract

Erythropoietin is known to be an essential hemopoietic growth factor for maturation of erythroid progenitor cells. Like other hemopoietic growth factors, erythropoietin acts as a survival factor that supports maturation of the erythroid progenitor through the suppression of apoptosis. It is unclear whether erythropoietin can also induce differentiation, or if another external regulator is needed to initiate this process. The present study using murine cell lines revealed that maturation of the erythroid lineage requires costimulation by activin A and erythropoietin. Erythropoietin alone dose not induce differentiation and cells stimulated by activin A alone undergo apoptotic death. Costimulation with erythropoietin and activin A, however, rescues the cells from apoptotic death and permits differentiation. Two-step cultivation showed that cells pretreated with activin A no longer need activin A and differentiate in the presence of erythropoietin alone. The action of activin A commits the cell to death or to differentiation, and the presence of erythropoietin enables differentiation through suppression of apoptosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9464268     DOI: 10.1006/bbrc.1997.8020

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

Authors:  Michael Dussiot; Thiago T Maciel; Aurélie Fricot; Céline Chartier; Olivier Negre; Joel Veiga; Damien Grapton; Etienne Paubelle; Emmanuel Payen; Yves Beuzard; Philippe Leboulch; Jean-Antoine Ribeil; Jean-Benoit Arlet; Francine Coté; Geneviève Courtois; Yelena Z Ginzburg; Thomas O Daniel; Rajesh Chopra; Victoria Sung; Olivier Hermine; Ivan C Moura
Journal:  Nat Med       Date:  2014-03-23       Impact factor: 53.440

Review 2.  Activins and Inhibins: Roles in Development, Physiology, and Disease.

Authors:  Maria Namwanje; Chester W Brown
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-07-01       Impact factor: 10.005

Review 3.  Where Does Lenalidomide Fit in Non-del(5q) MDS?

Authors:  Aristoteles Giagounidis
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

4.  Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.

Authors:  Benedetta Rambaldi; Elisa Diral; Samantha Donsante; Noemi Di Marzo; Federica Mottadelli; Lucia Cardinale; Erica Dander; Giuseppe Isimbaldi; Pietro Pioltelli; Andrea Biondi; Mara Riminucci; Giovanna D'Amico; Elena Maria Elli; Alice Pievani; Marta Serafini
Journal:  Ann Hematol       Date:  2020-10-21       Impact factor: 3.673

5.  Activin a in the regulation of corneal neovascularization and vascular endothelial growth factor expression.

Authors:  Vassiliki Poulaki; Nicholas Mitsiades; Friedrich E Kruse; Sven Radetzky; Eirini Iliaki; Bernd Kirchhof; Antonia M Joussen
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

6.  Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis.

Authors:  Rajasekhar N V S Suragani; Samuel M Cadena; Sharon M Cawley; Dianne Sako; Dianne Mitchell; Robert Li; Monique V Davies; Mark J Alexander; Matthew Devine; Kenneth S Loveday; Kathryn W Underwood; Asya V Grinberg; John D Quisel; Rajesh Chopra; R Scott Pearsall; Jasbir Seehra; Ravindra Kumar
Journal:  Nat Med       Date:  2014-03-23       Impact factor: 53.440

7.  Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia.

Authors:  Yingjie Qing; Xiangyuan Wang; Hongzheng Wang; Po Hu; Hui Li; Xiaoxuan Yu; Mengyuan Zhu; Zhanyu Wang; Yu Zhu; Jingyan Xu; Qinglong Guo; Hui Hui
Journal:  Cell Commun Signal       Date:  2021-08-09       Impact factor: 5.712

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.